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ABSTRACT. Fenugreek (Trigonella foenum-graecum L.) is a well-known 
herb for its efficiency in the prevention/treatment of diabetes among other 
chronic diseases. The aim of present study was to analyse the phytoconstituent 
profile of aqueous and hydro-alcoholic extracts of fenugreek seeds produced in 
Hungary. The aqueous and hydro-aqueous extracts were analysed using a 
UHPLC-ESI-MS approach, and in the first 54, while in the second extract 
67 phytoconstituents were identified that mostly corroborate the previously 
described health promoting effects of fenugreek. However, it remains a 
huge challenge to correlate the phytoconstituent composition of the two 
extracts with the generated dose dependent hormetic response and cytotoxic 
effects that were reported by us in case of some human breast cancerous 
cell lines.   
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INTRODUCTION  
 
The fenugreek (Trigonella foenum-graecum L.) has been grown in Asia, 
Africa and Europe from ancient times being utilized as a food (fresh shoots), 
spice (seed) and herbal remedy. Its popularity has ever been increasing so that 
recently, it is cultivated in countries like India, Pakistan, China, Russia, Greece, 
Turkey, Israel, Egypt, Sudan, Morocco, Tunisia, Germany, Austria, United Kingdom, 
Spain, Portugal, USA and Argentina. Due to its large cultivation areal, several 
fenugreek ecotypes and/or varieties were described upon taxonomical characters 
comprising morphological features like seed types. Furry (1950) was proposing six 
fenugreek seed types like Yemenese, Transcaucasian, African, Afghan, Chinese-
Persian and Indian, while Petropoulus (1973) had been suggesting categories like 
the Flourescent, Ethiopian, Indian and Mediterranean seed types [1,2]. 
Several beneficial biological and pharmacological properties are attributed 
to the fenugreek seeds such as anti-diabetic, hypocholesterolaemic, contraceptive 
and anti-fertility, gastric ulcer and wound healing, anti-cancer, anti-microbial, 
anthelmintic and anti-nociceptive effects, respectively [3].   
The fenugreek seeds contain (per 100g of edible portion): 369 calories, 
7.8% moisture, 28.2 g protein, 5.9 g fat, 54.5 g total carbohydrate, 8g fibre, 3.6 
g ash [4]. Fenugreek seeds containing diosgenin are considered one of the 
few natural sources of steroid sapogenins that is used for the synthesis of sex 
hormones, oral contraceptives and medicinally useful steroids [5]. Several 
furostanol saponins called trigoneosides Ia, Ib, IIa, IIb, IIIa, IIIb, IVa, Va, Vb, VI, 
VIIb, VIIIb, IX were isolated form fenugreek seeds originating from India [6,7]. 
Trigoneosides like Xa, Xb, XIb, XIIa, XIIb and XIIIa were identified from 
fenugreek seeds of the Egyptian origin [8]. Graecunins H-N are glycosides of 
diosgenin have also been isolated from fenugreek seeds, and belong to the 
spirostanol saponins [9]. Fenugrin B is another saponin that was also identified 
in fenugreek seeds [10]. Among sterols campesterol, stigmasterol, β-sitosterol 
and cholesterol were shown in different parts of the plant including seeds [11]. 
The fenugreek saponins exhibited hypocholesterolemic activity in rats [12]. 
Triterpenoids like lupeol, botulin, betulinic acid and soyasaponin were also 
isolated from fenugreek seeds [13]. Another important compound found in 
fenugreek seeds is the trigonelline which is the methylbetaine derivate of nicotinic 
acid, and its hypoglycemic and antipellagra effects have been demonstrated [14-
16]. The flavonoid content of fenugreek seeds had been intensively analysed, 
and it was suggested to confer antibacterial activity to seed extracts [17]. Quercetin, 
luteolin, vitexin, orientin, isoorientin, vicenin-1, vicenin-2, naringenin, kaempherol, 
7,4’-dimethoxyflavanone were identified among flavonoids. Other phenolic 
compounds were detected in different parts of plants (root, shoot, and pod) like 
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scopoleptin, trigocoumarin, chlorogenic, caffeic and coumaric acids [18]. Studies 
and estimations have shown that the 4-hydroxyisoleucine represents up to 30-
80 percent of free amino acid pool in fenugreek seeds [19,20]. A non-protein 
amino acid (S)-canavanine, and other amino acids like lysine and tryptophane 
were identified in fenugreek seeds [21,22]. The protein content of fenugreek 
leaves and seeds reaches 25-30 percent, so that approximately equals to that 
of soybeans [20]. It was suggested that the hypocholesterolemic effects of 
fenugreek seeds could be related to the amino acid content or to the relatively 
high fibre content (54 percent) and saponins (5 percent), [23]. Among vitamins 
in fenugreek seeds had been identified thiamine, riboflavin, pyridoxine, 
cyanocobalamine, niacin, Ca-pantothenate and biotin, while vitamin C was 
present mostly in the vegetative organs of the plant [24,25]. The lipid content of 
dried fenugreek seeds had been shown to reach approximately 7.5 percent, 
and the lipid profile consisted of neutral lipids (triacylglycerol, diacylglycerols, 
monoacylglycerols, free fatty acids, and sterols), glycolipids and phospholipids 
[26].  
In the current paper we are reporting the UHPLC-ESI-MS chemomapping 
of aqueous and hydro-alcoholic fenugreek seed extracts that were found by 
us to induce dose dependent hormetic response and cytotoxicity in case of 
human breast cancerous cell lines [27]. We were able to detect 54 and 67 
phytoconstituents in the aqueous and hydro-alcoholic artichoke extracts, 
respectively. Some of the newly identified compounds were confirmed by 
standards, while other have been already described by others [27-33]. 
 
 
 
RESULTS AND DISCUSSION 
 
The aqueous and the hydro-alcoholic extracts of fenugreek seeds were 
investigated with the reversed phase UHPLC-ESI-MS in positive and 
negative ionisation modes as described in Materials and Methods. The gradient 
mobile phase was based on acetonitrile and water. There have been 54 
phytoconstituents identified in the aqueous fenugreek seed extract as shown 
on Figure 1-2 and in Table 1. 
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Figure 1. Total ion chromatogram of aqueous extract of fenugreek  
in positive ionisation mode. 
 
 
 
 
Figure 2. Total ion chromatogram of aqueous extract of  
fenugreek in negative ionisation mode. 
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Table 1. Phytoconstituents identified in the aqueous fenugreek seed extract.  
Rt –retention time; [M+H]+ - molecular ion masses; [M+H]- - the found fragment ion 
mass; Ref- references; (*) [M]+; (**) confirmed by standards. 
 
Peak Rt  [M+H]+ [M-H]- Formula Fragment
s found 
Assignment Ref. 
1 1.27 104.10754*  C5H14NO 60.0814, 
59.0735 
Choline 27 
2 1.30 138.05550*  C7H8NO2 110.0601, 
96.0450 
Trigonelline 27 
3 1.31 175.11951  C6H14N4O2 158.0922, 
130.0975 
Arginine** 27 
4 1.31 148.06099  C5H9NO4 130.0863, 
102.0553 
Glutamic acid 27 
5 1.31 118.08681  C5H11NO2 59.0736, 
58.0657 
Betaine 27 
6 1.32 133.06132  C4H8N2O3 116.0342, 
88.0397 
Asparagine** 27 
7 1.43 189.12392  C8H16N2O3 172.0961, 
130.0863 
N-α-Acetyl-
lysine 
 
8 1.46 148.09737  C6H13NO3 130.0862, 
113.0598 
4-Hydroxyiso-
leucine 
27 
9 1.49 324.05968  C9H13N3O5 112.0507, 
95.0243 
Cytidine**  
10 1.51 146.09296  C5H11N3O2 128.0821, 
111.0555 
4-Guanidino-
butyric acid 
 
11 1.52 130.08681  C6H11NO2 84.0812, 
67.0548 
Pipecolic acid  
12 1.56 136.06233  C5H5N5 119.0352, 
94.0406 
Adenine  
13 1.66  283.06786 C10H12N4O6 151.0248, 
108.0188 
Xanthosine  
14 1.73  243.06171 C9H12N2O6 200.0558, 
153.0293 
Uridine  
15 1.75 170.08172  C8H11NO3 152.0704, 
134.0600
Pyridoxine** 27 
16 1.82 182.08172  C9H11NO3 165.0545, 
147.0439 
2-
Hydroxyphenyl-
alanine
 
17 1.96 123.05584  C6H6N2O 106.0287, 
96.0447 
Nicotinamide** 27 
18 2.01 330.06035  C10H12N5O6P 232.0828, 
136.0617 
Adenosine 3',5'-
cyclic 
monophosphate 
 
19 2.10 277.13997  C11H20N2O6 259.1286, 
213.1231 
Saccharopine  
20 2.23 385.12942  C14H20N6O5S 136.0618, 
134.0271 
S-Adenosyl-
homocysteine 
 
21 2.60 152.05724  C5H5N5O 135.0301, 
128.0455 
Guanine  
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Peak Rt  [M+H]+ [M-H]- Formula Fragment
s found 
Assignment Ref. 
22 2.63 282.08385 C10H13N5O5 150.0407, 
133.0142
Guanosine  
23 2.74 163.03952 C9H8O3 119.0487, 
93.0329
p-Coumaric acid  
24 2.95 268.10458  C10H13N5O4 136.0617, 
119.0358
Adenosine**  
25 3.10 252.10967  C10H13N5O3 136.0618, 
117.0548
2'-
Deoxyadenosine 
 
26 3.21 166.08681  C9H11NO2 149.0598, 
131.0493
Phenylalanine** 27 
27 4.86 220.11850  C9H17NO5 202.1073, 
184.0967
Pantothenic 
acid**
27 
28 6.49 205.09771  C11H12N2O2 188.0706, 
170.0599
Tryptophan** 27 
29 6.75 129.05517  C6H8O3 111.0443, 
101.0600
Sotolone  27 
30 8.31 190.05042  C10H7NO3 162.0547, 
144.0435
Kynurenic acid  
31 9.53 295.12940  C14H18N2O5 278.1017, 
232.0965 
γ-
Glutamylphenyl-
alanine
 
32 11.56 186.11302  C9H15NO3 168.1017, 
150.0909
Ecgonine  
33 12.32 593.15065 C27H30O15 503.1202, 
473.1087
Vicenin-2  28 
34 12.75 593.15065 C27H30O15 503.1215, 
473.1088 
Apigenin-di-C-
hexoside 
(Vicenin-2-
isomer)
28 
35 13.17 563.14009 C26H28O14 503.1187, 
473.1091
Vicenin-3  28 
36 13.74 449.10839  C21H20O11 395.0760, 
377.0658
Isoorientin  27 
37 13.75 563.14009 C26H28O14 503.1194, 
473.1096
Vicenin-1  28 
38 13.90 200.12867  C10H17NO3 182.1174, 
100.0759
Ecgonine methyl 
ester
 
39 14.43 577.15574 C27H30O14 503.1193, 
473.1097 
Apigenin-6-C-
glucoside-8-C-
rhamnoside 
28 
40 14.65 433.11348  C21H20O10 379.0805, 
361.0709
Isovitexin  27 
41 18.25 1195.57478 C56H92O27 705.3873, 
609.3632
Trigofoenoside 
G
31 
42 18.49 905.47461 C44H74O19 773.4326, 
611.3798
Trigoneoside Ia 29 
43 18.62 1063.53252 C51H84O23 609.3646, 
447.3091
Protoyuccageni
n-S4
31 
44 18.83 919.49026 C45H76O19 773.4315, 
611.3812
Trigoneoside Xa 30 
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Peak Rt  [M+H]+ [M-H]- Formula Fragment
s found 
Assignment Ref. 
45 18.84  905.47461 C44H74O19 773.4336, 
611.3795 
Trigoneoside Ib 29 
46 19.61  919.49026 C45H76O19 773.4322, 
611.3808 
Trigoneoside Xb 30 
47 19.73  887.46405 C44H72O18 593.3680, 
431.3171 
Trigoneoside VIII 30 
48 19.78  1225.58534 C57H94O28 1077.2218
901.4799 
Trigoneoside 
XIIIa 
30 
49 19.88  889.47970 C44H74O18 757.4387, 
595.3850 
Trigoneoside IIa 29 
50 19.98  1063.53252 C51H84O23 755.4216, 
593.3688 
Trigoneoside IVa 29 
51 20.00  1065.54817 C51H86O23 757.4368, 
595.3844
Trigofoenoside C 29 
52 20.10  1047.53760 C51H84O22 755.4216, 
575.3581 
Asparasaponin I 
(Protodioscin, 
Trigonelloside C) 
31 
53 20.30  901.47970 C45H74O18 755.4237, 
593.3704 
Trigoneoside 
XIIa 
30 
54 20.37  903.49535 C45H76O18 757.4390, 
595.3836 
Trigoneoside IIIa 29 
 
There have been 67 phytoconstituents identified in the hydro-
alcoholic fenugreek seed extract as shown in Table 2. 
 
 
Figure 3. Total ion chromatogram of hydro-alcoholic extract of fenugreek in 
positive ionisation mode. 
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Figure 4. Total ion chromatogram of hydro-alcoholic extract of fenugreek in 
negative ionisation mode. 
 
 
Table 2. Phytoconstituents identified in the hydro-alcoholic fenugreek seed extract.  
Rt –retention time; [M+H]+ - molecular ion masses; [M+H]- - the found fragment ion 
mass; Ref- references; (*) [M]+; (**) confirmed by standards. 
 
Peak Rt  [M+H]+ [M-H]- Formula Fragments 
found 
Assignment Ref. 
1 1.22 104.10754*  C5H14NO 60.0814, 
59.0736 
Choline 27 
2 1.32 138.05550*  C7H8NO2 110.0604, 
96.0447 
Trigonelline 27 
3 1.31 175.11951  C6H14N4O2 158.0923, 
130.0975 
Arginine** 27 
4 1.31 148.06099  C5H9NO4 130.0863, 
102.0553 
Glutamic acid 27 
5 1.31 118.08681  C5H11NO2 59.0736, 
58.0657 
Betaine 27 
6 1.40 189.12392  C8H16N2O3 172.0962, 
130.0862 
N-α-Acetyl-lysine  
7 1.42 146.09296  C5H11N3O2 128.0810, 
111.0556 
4-
Guanidinobutyric 
acid 
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Peak Rt  [M+H]+ [M-H]- Formula Fragments 
found 
Assignment Ref. 
8 1.46 130.08681  C6H11NO2 84.0812, 
67.0547 
Pipecolic acid  
9 1.63 124.03986  C6H5NO2 96.0448, 
80.0500 
Nicotinic acid** 27 
10 1.72  283.06786 C10H12N4O6 151.0248, 
108.0188 
Xanthosine  
11 1.73  243.06171 C9H12N2O6 200.0556, 
153.0292 
Uridine  
12 1.72 170.08172  C8H11NO3 152.0705, 
134.0601 
Pyridoxine** 27 
13 1.79 182.08172  C9H11NO3 165.0545, 
147.0440 
2-Hydroxyphenyl-
alanine 
 
14 1.93 123.05584  C6H6N2O 106.0288, 
96.0448 
Nicotinamide** 27 
15 2.09 277.13997  C11H20N2O6 259.1282, 
213.1233 
Saccharopine  
16 2.20 385.12942  C14H20N6O5S 136.0617, 
134.0270 
S-Adenosyl-
homocysteine 
 
17 2.62  282.08385 C10H13N5O5 150.0408, 
133.0142 
Guanosine  
18 2.66  163.03952 C9H8O3 119.0487, 
93.0331 
p-Coumaric acid  
19 2.95 268.10458  C10H13N5O4 136.0617, 
119.0358 
Adenosine**  
20 3.10 252.10967  C10H13N5O3 136.0617, 
117.0547 
2'-
Deoxyadenosine 
 
21 3.17 166.08681  C9H11NO2 149.0600, 
131.0492 
Phenylalanine** 27 
22 3.37 153.04126  C5H4N4O2 136.0142, 
110.0351 
Xanthine  
23 4.80 220.11850  C9H17NO5 202.1071, 
184.0967 
Pantothenic acid** 27 
24 6.33 205.09771  C11H12N2O2 188.0705, 
170.0597 
Tryptophan** 27 
25 6.75 129.05517  C6H8O3 111.0443, 
101.0601 
Sotolone  27 
26 8.35 190.05042  C10H7NO3 162.0547, 
144.0444 
Kynurenic acid  
27 9.50 295.12940  C14H18N2O5 278.1019, 
232.0964 
γ-Glutamylphenyl-
alanine 
 
28 9.94 134.04534  C4H7NO4 116.0344, 
88.0397 
Aspartic acid  
29 9.94 298.09739  C11H15N5O3S 163.0423, 
145.0318 
5'-S-Methyl-5'-
thioadenosine 
 
30 10.92  455.09680 C17H21N4O9P 255.0886, 
241.0725 
Flavin 
mononucleotide 
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Peak Rt  [M+H]+ [M-H]- Formula Fragments 
found 
Assignment Ref. 
31 11.53 186.11302  C9H15NO3 168.1018, 
150.0914 
Ecgonine  
32 11.81 271.06065  C15H10O5 253.0483, 
243.0648 
Genistein 56 
33 12.10  593.15065 C27H30O15 503.1193, 
473.1087 
Vicenin-2  28 
34 12.58  593.15065 C27H30O15 503.1192, 
473.1088 
Apigenin-di-C-
hexoside 
28 
35 12.81 193.05009  C10H8O4 178.0259, 
165.0544 
Scopoletin 27 
36 13.10  563.14009 C26H28O14 503.1177, 
473.1092 
Vicenin-3  28 
37 13.17 229.08647  C14H12O3 211.0754, 
183.0804 
Resveratrol  
38 13.52 449.10839  C21H20O11 395.0754, 
377.0649 
Isoorientin  27 
39 13.70  563.14009 C26H28O14 503.1196, 
473.1077 
Vicenin-1  28 
40 13.82 200.12867  C10H17NO3 182.1176, 
100.0602 
Ecgonine methyl 
ester 
 
41 13.96 433.11348  C21H20O10 415.1003, 
397.0918 
Vitexin  27 
42 14.33  577.15574 C27H30O14 503.1193, 
473.1084 
Apigenin-6-C-
glucoside-8-C-
rhamnoside 
28 
43 14.51 433.11348  C21H20O10 379.0811, 
361.0699
Isovitexin  27 
44 14.77  461.10839 C22H22O11 371.0772, 
353.0667 
Scoparin   
45 15.69 493.13461  C23H25O12 331.0806, 
316.0572 
Tricin-7-O-
glucoside 
57 
46 16.18 595.14517  C30H26O13 431.0971, 
413.0861 
Luteolin-8-C-(2''-
O-(E)-p-
coumaroyl-
glycoside) 
58 
47 17.53  271.06065   C15H12O5 227.0709, 
177.0181 
Naringenin  
48 18.12  1195.57478 C56H92O27 705.3867, 
609.3640
Trigofoenoside G 31 
49 18.36  905.47461 C44H74O19 773.4312, 
611.3799 
Trigoneoside Ia 29 
50 18.49  1063.53252 C51H84O23 609.3642, 
447.3113 
Protoyuccagenin-
S4 
31 
51 18.75  919.49026 C45H76O19 773.4318, 
611.3799 
Trigoneoside Xa 30 
52 18.91  905.47461 C44H74O19 773.4330, 
611.3799 
Trigoneoside Ib 29 
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Peak Rt  [M+H]+ [M-H]- Formula Fragments 
found 
Assignment Ref. 
53 18.97 331.08178  C17H14O7 316.0573, 
315.0494 
Tricin 27 
54 19.05  299.05556 C16H12O6 284.0326, 
256.0375 
Chrysoeriol 32 
55 19.57  887.46405 C44H72O18 593.3685, 
431.3164 
Trigoneoside VIII 30 
56 19.61  919.49026 C45H76O19 773.4322, 
611.3808 
Trigoneoside Xb 30 
57 19.62  1225.58534 C57H94O28 1077.98729
01.4840 
Trigoneoside XIIIa 30 
58 19.87  271.09704 C16H14O4 243.1017, 
161.0595 
Medicarpin 27 
59 19.67  889.47970 C44H74O18 757.4375, 
595.3850 
Trigoneoside IIa 29 
60 19.69  935.48518 C45H76O20 757.4380, 
595.3840 
Protoneogitogenin
-S5 
31 
61 19.79  1063.53252 C51H84O23 755.4224, 
593.3696 
Trigoneoside IVa 29 
62 19.74  1065.54817 C51H86O23 757.4377, 
595.3851 
Trigofoenoside C 29 
63 19.97  1047.53760 C51H84O22 755.4224, 
575.3589 
Asparasaponin I 
(Protodioscin, 
Trigonelloside C) 
31 
64 20.19  901.47970 C45H74O18 755.4287, 
593.3687 
Trigoneoside XIIa 30 
65 20.29  903.49535 C45H76O18 757.4388, 
595.3852 
Trigoneoside IIIa 29 
66 21.47  941.51100 C48H78O18 733.4561, 
615.3893 
Soyasaponin I  
67 27.22 457.36818  C30H48O3 411.3607, 
393.3505 
Ursolic acid  
 
 
 
 The phytoconstituents were defined based on specific retention time, 
accurate mass, isotopic distribution and fragmentation pattern, and by screening 
MS databases like Metlin, mzCloud and Massbank. All together the detected 
compounds could be rendered into ten categories of phytoconstituents, while 
the aqueous and hydro-alcoholic fenugreek seed extracts were featuring both 
similarities and differences with respect to their content (Table 3). 
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Table 3. Phytoconstituents identified in the aqueous and hydro-alcoholic fenugreek 
seed extracts. Compounds to be found only in aqueous extract are shown in blue, 
while compounds found only in hydro-alcoholic extracts are high lightened in yellow. 
 
Phytoconstituents Aqueous
fenugreek
Hydro- 
alcoholic 
fenugreek 
Alkaloids 
Ecgonine + + 
Ecgonine methyl ester + + 
Kynurenic acid + + 
Trigonelline + + 
Amino acids 2-Hydroxyphenylalanine + + 
4-Guanidinobutyric acid + + 
Arginine + + 
Asparaginea +  
Betaine (Trimethylglycine) + + 
Glutamic acid + + 
Aspartic acidb  + 
Phenylalanine + + 
Pipecolic acid + + 
Tryptophan + + 
N-α-Acetyl-lysine + + 
4-Hydroxyisoleucina +  
γ-Glutamylphenylalanine + + 
Coumarins Scopoletinb  + 
Flavonoids Naringeninb  + 
Chrysoeriolb  + 
Tricinb  + 
Luteolin-8-C-(2”-O-(E)-p-
coumaroylglycoside)b 
 + 
Tricin-7-O-glucosideb  + 
Genisteinb  + 
Vitexin (Apigenin-8-C-glucoside)b  + 
Isovitexin (Apigenin-6-C-glucoside)  + + 
Medicarpinb  + 
Scoparin (Chrysoeriol-8-C-
glucoside)b 
 + 
Vicenin-2 (6,8-Di-C-glucosylapigenin) + + 
Apigenin-di-C-hexoside (Vicenin-2-
isomer) 
+ + 
Vicenin-3 (6-C-Glucosyl-8-C-
xylosylapigenin) 
+ + 
Isoorientin (Homoorientin, Luteolin-6-
C-glucoside) 
 
+ 
+ 
Vicenin-1 (6-C-Xylosyl-8-C-
glucosylapigenin) 
+ + 
Apigenin-6-C-glucoside-8-C-
rhamnoside 
+ + 
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Phytoconstituents Aqueous
fenugreek
Hydro- 
alcoholic 
fenugreek 
Other 
metabolites 
Sotolone(3-Hydroxy-4,5-dimethyl-
2(5H)furanone) 
+ + 
Choline + + 
Saccharopine + + 
Polyphenols Resveratrolb  + 
p-Coumaric acid + + 
Purines and 
pyrimidine 
5'-S-Methyl-5'-thioadenosineb  + 
2'-Deoxyadenosine + + 
Adeninea +  
Adenosine + + 
Adenosine 3',5'-cyclic 
monophosphatea 
+  
Cytidinea +  
Flavin mononucleotide (FMN)b  + 
Guaninea +  
Guanosine + + 
S-Adenosylhomocysteine + + 
Uridine + + 
Xanthineb  + 
Xanthosine + + 
Saponins Soyasaponin Ib  + 
Trigoneoside Ia + + 
Trigoneoside Ib + + 
Trigoneoside IIa + + 
Trigoneoside IIIa + + 
Trigoneoside IVa + + 
Trigoneoside VIII + + 
Trigoneoside Xa + + 
Trigoneoside Xb + + 
Trigoneoside XIIa + + 
Trigoneoside XIIIa + + 
Asparasaponin I (Protodisocin,  
Trigonelloside C) 
+ + 
Trigofoneoside C + + 
Trigofoneoside G + + 
Protoneogitogenin-S5b  + 
Protoyuccagenin-S4 + + 
Terpenoid Ursolic acidb  + 
Vitamines Nicotinamide + + 
Nicotinic acid (B3, niacin)b  + 
Pantothenic acid (B5) + + 
Pyridoxine (B6) + + 
aCompounds to be found only in aqueous extract,  
bCompounds found only in hydro-alcoholic extracts  
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According to our current knowledge, we are the first to identify among 
the alkaloid type of compounds the ecgonine methyl ester and ecognine in 
fenugreek seed extracts. In mice, ecgonine methyl ester was shown to protect 
against cocaine lethality. This effect is consistent with its vasodilatory effects [34]. 
Moreover, we are reporting for the first time in fenugreek extracts the presence of 
kynurenic acid that is produced via the kynurenine pathway of tryptophan amino 
acid catabolism, the latest to be found in our both fenugreek extracts [35]. The 
neuroprotective role of kynurenic acid has been demonstrated [36]. Our 
experiments confirm the presence of trigonelline in our both fenugreek seed 
extracts. Trigonelline was shown to inhibit Nrf2 together with blocking of Nrf2-
dependent expression of proteasomal genes [37].  
We were able to detect the 4-hydroxyisoleucin, the most abundant amino 
acid in fenugreek seeds together with asparagine both being only present in 
the aqueous extract. Aspartic acid was present only in the hydro-alcoholic 
fenugreek seed extract, while all the other amino acids listed in Table 3 could 
be found in both extracts. 
Among coumarins we are reporting for the first time the identification 
of scopoletin in hydro-alcoholic extract of fenugreek seeds, a compound that 
has already described in fenugreek root, shoot, pod, stem and leaves [18, 38]. 
Scopoleptin was suggested to have an important anti-inflammatory effect by 
inhibiting the phosphorylation of NF-κB and p38 MAPK in mice [39], and to 
inhibit human tumor vascularization in xenograft models [40].  
Flavonoids like naringenin, vitexin (apigenin-8-C-glucoside), luteolin-
8-C-(2”-O-(E)-p-coumaroylglycoside, isoorientin, vicenin-1, vicenin-2, vicenin-3 
(6-C-glucosyl-8-C-xylosylapigenin), apigenin-6-C-glucoside-8-C-rhamnoside, 
chrysoeriol and tricin had been reported already in fenugreek seeds [5, 28-33]. 
However, flavonoids like, tricin-7-O-glucoside, genistein, isovitexin (apigenin-6-C-
glucoside), medicarpin, scoparin and apigenin-6-C-glucoside-8-C-rhamnoside 
are revealed for the first time in fenugreek seed extracts.  
The scoparin is a chrysoeriol glucoside and its biological effects are not 
known. In case of chrysoeriol was shown to partly inhibit adipogenesis by blocking 
the accumulation of triacylglycerol in the 3T3-L1 cells [41]. Moreover, it was 
demonstrated that chrysoeriol is a PI3K-AKT-mTOR pathway inhibitor with 
potent antitumor activity against human multiple myeloma cells in vitro [42].  
The genistein is an estrogen agonist phytoestrogen, and when isolated 
from soy, it is reported to display neuroprotective effects against neuronal death 
in animal models [43]. Experimental data suggested that genistein may exhibit 
anticancer properties on HT29 colon cancer cells by modulating caspase-3 
and p38 MAPK pathway at different transcriptional and protein levels [44]. 
The isovitexin (apigenin-6-C-glucoside), an isomer of vitexin, generally 
occurring together with vitexin, and together are exhibiting diverse biological 
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activities like anti-oxidant, anti-cancer, anti-inflammatory, anti-hyperalgesic, and 
neuroprotective effects [45]. 
The medicarpin was shown to have osteogenic activity promoting bone 
regeneration by activating Wnt and Notch signalling pathway [46]. Medicarpin 
it was suggested to have pro-apoptotic effects against drug-sensitive (P388) 
and multidrug resistant P388 leukemia cells [47]. 
The polyphenol content of fenugreek seeds was also analysed, and 
the presence of resveratrol had been demonstrated for the first time in our 
hydro-alcoholic extract. Resveratrol was shown to affect lipids and arachidonic 
acid metabolisms, and together with its antioxidant activity elicited a great 
research interest in fields such as cancer, neurodegenerative and cardiovascular 
diseases and metabolic disorders [48].  
Trigocoumarin and caffeic acid seemed to be present at a low abundance 
in our aqueous fenugreek seed extract as suggested by the molecular mass 
corresponding peaks, and the structure confirming isotopic pattern, but no 
fragmentation profiles were generated hence they have not been included in 
the tables with phytoconstituents. 
The quercetin, p-coumaric acid and chlorogenic acid were poorly detectable 
in both extracts, and again the fragmentation profile based evidences are 
missing, yet molecular masses and isotopic patterns are available. Nevertheless 
they have not been included into the tables with phytoconstituents. 
Among metabolites we were able to identify sotolone (3-Hydroxy-4,5-
dimethyl-2(5H)furanone), choline and saccharopine as new phytoconstituents 
in fenugreek seed extracts. We have to admit that sotolone was also detected in 
fenugreek hairy root cultures [49]. The sotolone is known to impart powerful 
Madeira-oxidized-curry-walnut notes to various hydro-alcoholic beverages. It 
has been much studied in oxidized Jura flor-sherry wines, dry white wines, 
aged Roussillon sweet wines, and old Port wines, in which it contributes to 
the characteristic "Madeira-oxidized" aroma of these beverages [50]. However, the 
sotolone biological effects are not known, though it was shown to interfere 
with the maple syrup urine disease, which is a rare autosomal-recessive metabolic 
disorder caused by a deficit of oxidative decarboxylation of branched-chain 
amino acids [51].    
The choline is another phytoconstituent that we show to be present in 
both of our fenugreek seed extracts. It has been demonstrated that choline 
supplementation in insulin resistant (IR) mice would ameliorate muscle 
function by remodelling glucose and fatty acid (FA) metabolism [52]. This will 
be achieved by the reduction of glucose utilization for FA and triglyceride (TAG) 
synthesis, and increased muscle storage of glucose as glycogen. It was 
demonstrated that a choline reach diet would prevent non-alcoholic fatty 
liver. 
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We have identified for the first time the saccharopine in fenugreek seed 
extracts. Lysine is catabolized in developing plant tissues through the 
saccharopine pathway, and have been shown to be involved in the development 
of maize seed and stress responses [53]. In the case of mammalian myotubes, 
saccharopine was shown to stimulate Akt and mTOR signalling that has 
suppressed autophagic-proteolysis, and might reduce muscle wasting [54]. 
Purines and pyrimidine such as 5'-S-Methyl-5'-thioadenosine, 2'-
deoxyadenosine, adenine, adenosine, adenosine 3',5'-cyclic monophosphate, 
cytidine, flavin mononucleotide (FMN), guanine, guanosine, S-adenosyl-
homocysteine, uridine and xanthine have been identified for the first time in 
fenugreek seed extracts. The presence of 5'-S-methyl-5'-thioadenosine in 
apples was correlated with the conversion of methionine related to ethylene 
biosynthesis [55]. S-adenosylhomocysteine is the by-product of all S-
adenosylmethionine-dependent transmethylation reactions, and its presence 
seems to be related to cardiovascular disease, kidney disease, diabetes, and 
obesity [56].   
The presence of saponins was extensively studied in the case of 
fenugreek including the vegetative organs and seeds of the plant [6-11]. The 
trigoneoside profile of our fenugreek seeds was different from that described 
for those originated from India and Egypt, respectively. Trigoneosides such 
as Ia, Ib, IIa, IIIa and IVa were present, while trigoneosides like IIb, IIIb, Va, Vb, 
VI, VIIb, VIIIb and IX were absent from our extracts as compared to the Indian 
fenugreek seed. On the other hand, trigoneosides like Xa, Xb, XIIa and XIIIa 
were identified, though trigoneosides like XIb and XIIb were missing from our 
fenugreek seed extracts as compared to the seeds of Egyptian origin. We 
were able to detect soyasaponin I in our fenugreek seed hydro-alcoholic extract. 
Soyasaponin I was shown to inhibit the Renin- Angiotensin- Aldosterone 
System, so it could be considered a potent native anti-hypertensive compound 
that has to be further tested [57]. However, diosgenin, gitogenin, tigogenin 
and betulin were poorly detectable in our hydro-alcoholic seed extract, while 
only traces of graecunin B, lupeol and betulinic acid were found in both of our 
seed extracts. We have to admit that due to the relatively law abundance of 
the above mentioned saponins in our extracts, we were unable to generate 
fragmentation profiles, so that their presence, was defined by the molecular 
mass corresponding peaks, and the structure confirming isotopic pattern. 
Neotigenin and fenugrin B were absent from our fenugreek seed extracts. It 
seems therefore likely that our fenugreek seed features a specific saponin 
profile, and that is clearly distinct from that were previously described. This it 
means that the hypocholesterolemic activity attributed to the saponin content 
of earlier described fenugreek seeds has to be carefully re-examined in the 
case of the fenugreek seed used in our experiments [12].  
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We were able to identify in our fenugreek seed extracts some of the 
already reported B group vitamins like niacin, pantothenic acid and pyridoxine, 
while nicotinamide was detected for the first time, but biotin was absent 
[24,25]. The thiamine, riboflavine, cyanocobalamin and vitamin C were hardly 
detectable in our fenugreek seed extracts, so in the absence of fragmentation 
profiles, their presence could only be confirmed by the molecular mass 
corresponding peaks, and the structure specific isotopic pattern. It has been 
suggested that some of the B vitamins act as cancer risk reduction agent 
[58], and having anti-inflammatory effects associated with atherosclerosis 
and autoimmunity [59]. 
We were also able to identify for the first time among terpenoids the 
ursolic acid that was present only in the hydro-alcoholic fenugreek seed extract. 
It has been demonstrated that the ursolic acid exerted anti-oxidative and anti-
inflammatory effects on mouse brain injury model by activating the Nrf2-ARE 
pathway [60], while its anti-cancer and anti-metastatic effects were also proven 
[61,62]. 
 
 
CONCLUSIONS 
 
The comparative chemomapping of aqueous and hydro-alcoholic 
fenugreek seed extracts revealed already known and new phytoconstituents 
that further support the antidiabetic effects of fenugreek seeds. Originally, these 
antidiabetic effects were attributed mainly to galactomannan, 4-hydroxyisoleucin 
(4-OH-Ile), diosgenin and trigonelline [63]. It had been shown that these 
compounds featured direct antidiabetic properties in clinical studies by increasing 
insulin secretion (4-OH-Ile), decreasing insulin resistance and glucose resorption 
(galactomannan), and improvement in B-cells regeneration (trigonelline). 
Moreover, the presence of such phytoconstituents in our extracts is expected 
to improve blood lipid spectre (4-OH-Ile, diosgenin), and to show reno-protective 
(4-OH-Ile, trigonelline), neuroprotective (trigonelline) and antioxidant (diosgenin, 
trigonelline) properties. Other phytoconstituents identified in our seed extracts 
plead for a more substantial neuroprotective (kynurenine, genistein, vitexin, 
isovitexian), anti-inflammatory (trigonelline, scopoletin, ursolic acid, vitamins), 
hypocholesterolemic (saponins), muscle and/or hepatic insulin resistance 
reducing (choline) effects. However, when the phytoconstituent profile of saponins 
from Hungarian seeds was compared to the previously reported Indian and 
African seeds some differences were imminent. These differences were of 
qualitative nature but it seems logic to envision other dissimilarities at the 
quantitative level too. The ecological and cultivation conditions together with the 
genome based specificities are going to influence the qualitative and quantitative 
phytoconstituent profile of any fenugreek cultivated variety. This is the reason 
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why the careful assessment of chemical composition of fenugreek seeds from 
different sources is of great importance especially if they are intended for 
human consumption. 
Given the large body of phytoconstituents found in fenugreek seed 
with effects that span across a wide health promoting spectrum, the future 
studies are expected to shed light on the quantitative parameters, and the 
cellular mechanisms attributed to such extracts. In this respect, remains to 
be elucidated whether such a multi phytoconstituent extract elicits an 
overcompensation to a disruption of homeostasis or a direct stimulatory 
response. It is expected that both overcompensation/disruption of homeostasis 
or stimulatory response will be below the toxic threshold, yet highly consistent 
with the hormetic concentration-response model [64]. This is exactly the case 
for our aqueous fenugreek seed extract that at very low concentrations 
increases the viability and division rate of human breast cancerous cells, while 
at high concentrations is exceedingly cytotoxic [27]. Moreover, our hydro-
alcoholic fenugreek seed extract features only cytotoxicity and no evident 
dose-dependent hormetic response. Taken together our paper is one such an 
attempt that tries to correlate the phytoconstituent profile of fenugreek seed 
extracts with their corresponding biological effect seen in case of human 
breast cancerous cell lines. More system biology type of experiments are 
needed to unravel the complexity of beneficial effects of fenugreek. 
EXPERIMENTAL SECTION 
x. Materials and methods
x.1. Chemicals and reagents 
Acetonitrile, water and formic acid were procured from Fisher Scientific 
(Geel, Belgium), while ammonium acetate and ammonium formate were 
from Sigma-Aldrich (Munich, Germany). 
x.2. Plant material 
The fenugreek seeds were obtained from TRIGONELLA MED. LTD., 
Mosonmagyaróvár, Hungary. 
x.3. Sample preparation  
The aqueous extract was obtained by boiling 5g fenugreek dried 
seeds in 100 ml water for 5 minutes then left to cool down at room 
temperature and centrifuged for 10 minutes at 4000 rpm. The obtained 
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supernatant was filtered through Whatman filter paper, and aliquots stored 
in 15 ml Falcon tubes at -20°C freezer up until their use. 
To obtain the hydro-alcoholic (ethanol : water 1:1) extract, 5 g dried 
fenugreeks seeds were extracted two times with 500 ml ethanol–water (1:1) 
by stirring for 4h at 40 °C. The generated primary extract was centrifuged at 
4000 rpm for 10 min at room temperature, and finally the ethanol was removed 
using a rotation vacuum evaporator. The ethanol free extract was filtered using a 
45 µm Milipore filter unit and stored at 4°C until further studies. 
 
x.4. UHPLC-ESI-MS analysis 
A Dionex Ultimate 3000RS UHPLC system equipped with a Thermo 
Accucore C18 column, 100/2.1 with a particle size of 2.6 μm was coupled to a 
Thermo Q Exactive Orbitrap mass spectrometer equipped with an electrospray 
ionization source (ESI), and the measurement accuracy was within 5ppm. The 
mass spectrometer was operated at 320°C capillary temperature, 4.0 kV in 
positive mode and 3.8 kV in negative mode of spray voltage, and a resolution 
of 35,000 in the case of MS, while 17,500 was for MS/MS. The 100-1000 m/z 
was the scanned mass interval. For MS/MS scans the collision energy was 
40NCE. The difference between measured and calculated molecular ion 
masses were always below 5 ppm. 
In case of positive ionization mode UHPLC separation, a specific eluent 
A (500 ml of water containing 10 ml of acetonitrile, 0.5 ml of formic acid and 
2.5 mM of ammonium formate) and eluent B (500 ml of acetonitrile containing 
10 ml of water, 0.5 ml of formic acid and 2.5 mM of ammonium formate) 
combination was used. 
For the negative ionization mode UHPLC separation, another combination 
of eluent A (500 ml of water containing 10 ml of acetonitrile and 2.5 mM of 
ammonium acetate) and eluent B (500 ml of acetonitrile containing 10 ml of 
water and 2.5 mM of ammonium acetate) was applied. 
The flow rate was set for 200 μl/min, and the same gradient elution 
program was used both positive and negative ionization mode type of 
determinations (0-1 min, 95% A, 1-22 min, 20% A; 22-24 min, 20% A; 24-26 
min, 95% A; 26-40 min, 95% A). 5 μl of aqueous or hydro-alcoholic fenugreek 
seed extracts were injected at every run. 
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